Protein in Medical Definition

Muscle atrophy

... occurs by a change in the normal balance between protein synthesis and protein degradation. During atrophy, there is a down-regulation of protein synthesis pathways, and an activation ...

Proteopathy

... [3] [4] The proteopathies are also called protein conformational diseases , [5] because a change in the 3-dimensional folding (conformation) of a protein increases the tendency of the protein to misfold and polymerize into aggregates that ...

Thymocyte

... by the T cell receptor , which is a surface protein able to recognise short protein sequences ( peptides ) that are presented on MHC ... is capable to binding a pre-T cell receptor alpha protein and assembling on the surface with the signalling ...

Atransferrinemia

... 209300 DiseasesDB 29538 Atransferrinemia is a genetic disorder in which there is absence of transferrin , a plasma protein that transports iron through the blood . Atransferrinemia is characterized by anemia and hemosiderosis in the heart and liver . The iron ...

Cryostasis (clathrate hydrates)

... Am. J. Physiol. 1984;247:125–147 . Retrieved on 2007 - 01-03 . ^ Graham L.A., Liou Y.-C., Walker V. K., Davies P. L. Hyperactive antifreeze protein from beetles. Nature 1997;388:727–728 . Retrieved on 2007 - 01-03 . ^ Fletcher G.L., Hew C.L., Davies P.L. Antifreeze Proteins of Teleost ...

Neurobiological Brain Disorder

... and Psychiatric Manifestations: Identifying hypothyroidism’s psychiatric presentations Lingering Psychiatric Symptoms From Hyperthyroidism protein Biomarkers for Schizophrenia Studied in Cerebrospinal Fluid ...

Neuropsychiatry

... Keck, P.E, McElroy, S L, Alexander, L., Shaw, S.H., & Kelsoe, J. (2003) Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder. Molecular Psychiatry, 8, 546−557. Baughman, F.A., & Hovey, J. (2006) The ADHD ...

Personalized medicine

... theranostic test. Herceptin treats a category of breast cancer in woman and the test helps identify those patients whose cancer cells express the protein HER2 making them eligible. Herceptin sales have grown from $30.5 million in 1998, its year of introduction, to $764 million in 2005. Gleevec treats ...